{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:01:25Z","timestamp":1784383285003,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,10]]},"DOI":"10.7759\/cureus.58004","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T04:46:36Z","timestamp":1712810796000},"source":"Crossref","is-referenced-by-count":3,"title":["A Case of Anti-Synthetase Syndrome With Anti-Glycyl tRNA Synthetases Antibody Developed After COVID-19"],"prefix":"10.7759","author":[{"given":"Yusuke","family":"Irie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Matuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Hiruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1002329","article-title":"New-onset dermatomyositis following COVID-19: a case report","volume":"13","author":"Shimizu H","year":"2022","unstructured":"Shimizu H, Matsumoto H, Sasajima T, et al.. New-onset dermatomyositis following COVID-19: a case report. Front Immunol. 2022, 13:1002329. 10.3389\/fimmu.2022.1002329","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis HE","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023, 21:133-46. 10.1038\/s41579-022-00846-2","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt LJ","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016, 23:218-26. 10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2021.2024019","article-title":"Anti-synthetase syndrome occurring after SARS-CoV-2 infection","volume":"51","author":"Bouchard Marmen M","year":"2022","unstructured":"Bouchard Marmen M, Ellezam B, Fritzler MJ, et al.. Anti-synthetase syndrome occurring after SARS-CoV-2 infection. Scand J Rheumatol. 2022, 51:255-7. 10.1080\/03009742.2021.2024019","journal-title":"Scand J Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4031","article-title":"A case of antisynthetase syndrome initially presented with interstitial lung disease mimicking COVID-19","volume":"14","author":"Elsayed M","year":"2023","unstructured":"Elsayed M, Abdelgabar A, Karmani J, Majid M. A case of antisynthetase syndrome initially presented with interstitial lung disease mimicking COVID-19. J Med Cases. 2023, 14:25-30. 10.14740\/jmc4031","journal-title":"J Med Cases"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2022-0444","article-title":"A case of antisynthetase syndrome presenting solely with life-threatening interstitial lung disease","volume":"23","author":"Tranah E","year":"2023","unstructured":"Tranah E, MacBrayne A, Bhadauria N, Mukerjee D. A case of antisynthetase syndrome presenting solely with life-threatening interstitial lung disease. Clin Med (Lond). 2023, 23:85-7. 10.7861\/clinmed.2022-0444","journal-title":"Clin Med (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab129","article-title":"Anti-PL-7 antisynthetase syndrome presenting as COVID-19","volume":"60","author":"Blake T","year":"2021","unstructured":"Blake T, Noureldin B. Anti-PL-7 antisynthetase syndrome presenting as COVID-19. Rheumatology (Oxford). 2021, 60:e252-4. 10.1093\/rheumatology\/keab129","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1590\/s1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon J","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011, 37:100-9. 10.1590\/s1806-37132011000100015","journal-title":"J Bras Pneumol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead110","article-title":"Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis\/polymyositis therapeutic trials and consensus profiles","volume":"62","author":"Saygin D","year":"2023","unstructured":"Saygin D, Kim H, Douglas C, et al.. Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis\/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023, 62:3672-9. 10.1093\/rheumatology\/kead110","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40588","article-title":"A case of antisynthetase syndrome in the setting of SARS-Cov-2 infection","volume":"15","author":"Pe\u00f1a C","year":"2023","unstructured":"Pe\u00f1a C, Kalara N, Velagapudi P. A case of antisynthetase syndrome in the setting of SARS-Cov-2 infection. Cureus. 2023, 15:e40588. 10.7759\/cureus.40588","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.03.022","article-title":"Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias","volume":"105","author":"Watanabe K","year":"2011","unstructured":"Watanabe K, Handa T, Tanizawa K, et al.. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med. 2011, 105:1238-47. 10.1016\/j.rmed.2011.03.022","journal-title":"Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202008-1002OC","article-title":"Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment","volume":"18","author":"Myall KJ","year":"2021","unstructured":"Myall KJ, Mukherjee B, Castanheira AM, et al.. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021, 18:799-806. 10.1513\/AnnalsATS.202008-1002OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0536-x","article-title":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","volume":"33","author":"Tian S","year":"2020","unstructured":"Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao SY. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020, 33:1007-14. 10.1038\/s41379-020-0536-x","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu Z","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, et al.. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020, 8:420-2. 10.1016\/S2213-2600(20)30076-X","journal-title":"Lancet Respir Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","volume":"15","author":"Tian S","year":"2020","unstructured":"Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020, 15:700-4. 10.1016\/j.jtho.2020.02.010","journal-title":"J Thorac Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0325-y","article-title":"Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy","volume":"16","author":"Sasano H","year":"2016","unstructured":"Sasano H, Hagiwara E, Kitamura H, et al.. Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulm Med. 2016, 16:168. 10.1186\/s12890-016-0325-y","journal-title":"BMC Pulm Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29493","article-title":"Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China","volume":"96","author":"Wu N","year":"2024","unstructured":"Wu N, Chen Z, Zha G, et al.. Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China. J Med Virol. 2024, 96:e29493. 10.1002\/jmv.29493","journal-title":"J Med Virol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155873","article-title":"SARS-CoV-2 triggering autoimmune diseases","volume":"154","author":"Mobasheri L","year":"2022","unstructured":"Mobasheri L, Nasirpour MH, Masoumi E, Azarnaminy AF, Jafari M, Esmaeili SA. SARS-CoV-2 triggering autoimmune diseases. Cytokine. 2022, 154:155873. 10.1016\/j.cyto.2022.155873","journal-title":"Cytokine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36686-8","article-title":"SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity","volume":"14","author":"Jaycox JR","year":"2023","unstructured":"Jaycox JR, Lucas C, Yildirim I, et al.. SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity. Nat Commun. 2023, 14:1299. 10.1038\/s41467-023-36686-8","journal-title":"Nat Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/232950-a-case-of-anti-synthetase-syndrome-with-anti-glycyl-trna-synthetases-antibody-developed-after-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T04:46:39Z","timestamp":1712810799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/232950-a-case-of-anti-synthetase-syndrome-with-anti-glycyl-trna-synthetases-antibody-developed-after-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.58004","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,10]]}}}